Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD4360 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AZD4360, a putative antibody-drug conjugate (ADC) targeting CLDN18.2 (Apr 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD4360 | AZD-4360|AZD 4360 | CLDN18.2 Antibody 23 | Limited information is currently available on AZD4360, a putative antibody-drug conjugate (ADC) targeting CLDN18.2 (Apr 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06921928 | Phase Ib/II | AZD4360 | Study for AZD4360 in Participants With Advanced Solid Tumours | Recruiting | USA | GBR | DEU | 2 |